Therefore, the Aβ25‐35 model allows to examine a drug effect quickly and in large cohort of animals, on a plethora of parameters descriptive of the AD pathology rendering it a model of choice to exemplify the neuroprotective potential of UW‐MD‐95 as a new neuroprotective BChE inhibitor. This evidence concerns the gene BCHE and Alzheimer disease.